There’s no debate. Today, pharmaceutical, biotech and life sciences companies are making AI a strategic priority. The ambition is clear and even heroic: Accelerate drug discovery, improve clinical trial design, automate routine tasks, generate real-world evidence and bring therapies to patients faster.
Data governance for AI: The key life science and biotech prescription
calendar_today
October 8, 2026
domain
collibra